Align Biopharma Introduces New Technology Standard to Enable Single Sign-on for Healthcare Providers
October 10 2017 - 7:03AM
Business Wire
Final identity management standard will make it
easier for HCPs to access online content across life sciences
companies
Align Biopharma™, a life sciences industry technology standards
group, today published a final open technology standard for
identity management. Members from leading pharmaceutical,
technology, and service provider companies reviewed and defined the
technical requirements for products to enable a single sign-on
service for healthcare professionals (HCPs). The new standard is a
major step forward in the industry and will make it faster and
easier for HCPs to access online content across all life sciences
companies.
“A common identity management standard will improve the
experience for healthcare providers,” said Scott Cenci, vice
president of global markets IT at Biogen (NASDAQ: BIIB). “The
industry is making it easier for healthcare professionals to
connect with biopharma companies. Ultimately, when we improve their
user experience with digital engagement and information access, we
can better help patients.”
The process for HCPs to access online content is complex and
requires multiple logins across various biopharma company websites,
portals, and virtual events. The identity management standard aims
to improve how life sciences companies and their customers interact
and streamline HCP access to the drug and treatment information
required to facilitate patient engagement.
“It’s difficult keeping track of all the username and password
combinations required to access information from biopharma
companies,” said David S. Wernsing, M.D., FACS, bariatric surgeon
at Penn Medicine. “Having a fast and convenient way to log into
various digital sites and applications will dramatically simplify
how I connect with the life sciences industry and deliver care to
patients.”
The Align Biopharma identity management standard is now ready
for technology providers to create solutions that are certified
with the standard. As certified products become available in the
market, biopharma companies can adopt these solutions to address
HCPs’ challenges with identity management across various digital
channels.
“Align Biopharma represents the industry coming together to put
the customer first and transform the HCP experience,” said Henry
Levy, president of Align Biopharma. “With our first standard now
available, our goal is to deepen collaboration to build technology
solutions and encourage their broad adoption in life sciences so we
can better connect companies and HCPs.”
Align Biopharma has become a fast-growing influence in the
industry to create and implement open technology standards. The
group includes a total of 23 members from leading pharmaceutical,
technology, and service provider companies dedicated to making it
easier for healthcare professionals to connect digitally with life
sciences companies.
For more information on Align Biopharma, visit
AlignBiopharma.org to learn about its mission and current standards
in development.
Additional Information
Connect with Align Biopharma on LinkedIn:
http://linkedin.com/company/align-biopharmaFollow @alignbiopharma
on Twitter: twitter.com/alignbiopharma
About Align Biopharma
Align Biopharma is an industry standards group founded by top
global pharmaceutical companies and Veeva Systems. The group
includes more than 20 leading pharmaceutical, technology, service
provider companies that are dedicated to making it faster and
easier for healthcare professionals to connect with the life
sciences industry. For more information, visit
AlignBiopharma.org.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171010005638/en/
Barbadora InkLisa Barbadora,
610-420-3413lbarbadora@barbadoraink.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2023 to Apr 2024